What gastrointestinal side effects should Crohn's patients watch for with GLP-1 medications
Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis
Semaglutide may work through a combination of mechanisms: direct brain receptor activation, reduced inflammation, improved metabolic health, and the psychological boost of visible physical results
Side effects should subside
Semaglutida oral 50 mg administrada una vez al da en adultos con sobrepeso u obesidad (OASIS 1): un ensayo aleatorizado, doble ciego, controlado con placebo, de fase 3 Un ensayo aleatorizado, doble ciego y controlado con placebo evalu la seguridad y la efectividad del semaglutide oral (GLP-1) 50 mg, administrado una vez al da en adultos con sobrepeso u obesidad que no tenan diabetes tipo 2
No major professional guidelines, including those from the American Psychiatric Association and Academy for Eating Disorders, currently recommend GLP-1/GIP receptor agonists for the treatment of BED outside of research settings